| Literature DB >> 30281689 |
Diego Vidaletti Silva1, Gustavo Waclawovsky1, Ana Beatriz Kramer1,2, Cinara Stein1, Bruna Eibel1, Guilherme Brasil Grezzana1, Maximiliano Isoppo Schaun1, Alexandre Machado Lehnen1,2.
Abstract
BACKGROUND: Cardiac remodeling is a specific response to exercise training and time exposure. We hypothesized that athletes engaging for long periods in high-intensity strength training show heart and/or vascular damage.Entities:
Mesh:
Year: 2018 PMID: 30281689 PMCID: PMC6263448 DOI: 10.5935/abc.20180167
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
General characteristics of the study participants
| PG (n = 16) | RG (n = 24) | p-value | |
|---|---|---|---|
| Age (years) | 29.9 ± 4.4 (27.5–32.2) | 28.7 ± 5.7 (26.3–31.1) | 0.490 |
| Body mass (kg) | 99.2 ± 21.5 (87.6–110.7) | 71.7 ± 9.2 (67.7–75.6) | < 0.001 |
| Height (cm) | 176 ± 0.8 (172–181) | 175 ± 0.8 (172–179) | 0.736 |
| Chest circumference (cm) | 113.2 ± 13.4 (106–120.4) | 86.9 ± 8.6 (83.2–90.5) | < 0.001 |
| Waist circumference (cm) | 95.1 ± 12.9 (88.2–102) | 78.6 ± 5.7 (76.2–81.1) | < 0.001 |
| Duration of training (years) | 5.12 ± 2.0 (4.0–6.2) | 7.8 ± 2.6 (6.7–8.9) | 0.001 |
| Weekly duration of training (days) | 3.9 ± 1.0 (3.3–4.4) | 5.4 ± 1.0 (4.9–5.8) | < 0.001 |
| Daily duration of training (min/day) | 69.3 ± 14.4 (61.7–77.0) | 98.7 ± 28.6 (86.6–110.8) | 0.001 |
PG: powerlifters group; RG: long-distance runners group. Weekly number of training sessions and session average time correspond to the average duration for the last 3 months. Differences between means were assessed using Student’s t Test for independent samples.
Maximum load test results in absolute values and adjusted for body mass
| PG (n = 16) | RG (n = 24) | p-value | ||
|---|---|---|---|---|
| Squat (kg) | 212.2 ± 46.4 (187.4–236.9) | 98.9 ± 27.1 (87.4–110.6) | < 0.001 | |
| Squat/body mass | 2.16 ± 0.27 (2.01–2.30) | 1.37 ± 0.30 (1.24–1.50) | < 0.001 | |
| Bench press (kg) | 145.5 ± 32.9 (127.9–163.1) | 59.0 ± 16.5 (52.0–66.0) | < 0.001 | |
| Bench press/body mass | 1.49 ± 0.26 (1.35–1.62) | 0.81 ± 0.17 (0.74–0.89) | < 0.001 | |
| Deadlift (kg) | 239.0 ± 66.5 (203.6–274.5) | 102.4 ± 27.8 (90.6–114.2) | < 0.001 | |
| Deadlift/body mass | 2.43 ± 0.49 (2.16–2.69) | 1.45 ± 0.41 (1.28–1.63) | < 0.001 | |
| Total load (kg) | 596.8 ± 137.4 (532.6–670.1) | 260.4 ± 43.8 (241.9–278.9) | < 0.001 | |
| Total load/body mass | 6.07 ± 0.89 (5.59–6.55) | 3.64 ± 0.48 (3.44–3.85) | < 0.001 |
PG: powerlifters group; RG: long-distance runners group. Differences between means were assessed by Student's t Test for independent samples.
Hemodynamic and cardiopulmonary parameters
| PG (n = 16) | RG (n = 24) | p-value | |
|---|---|---|---|
| Resting SBP (mmHg) | 130.0 ± 8.2 (124.5–134.0) | 116.4 ± 8.6 (112.8–120.1) | < 0.001 |
| Resting DBP (mmHg) | 82.1 ± 6.9 (78.1–68.1) | 72.0 ± 6.5 (69.3–74.8) | < 0.001 |
| Resting heart rate (bpm) | 80.4 ± 7.5 (76.0–84.8) | 64.7 ± 10.3 (60.3–69.1) | < 0.001 |
| Maximum heart rate (bpm) | 180.2 ± 13.7 | 184.3 ± 14.7 | 0.403 |
| VO2 max (mL.kg-1.min-1) | 33.9 ± 7.5 (29.6–38.9) | 56.0 ± 7.3 (52.7–62.1) | < 0.001 |
| VCO2 max (mL.kg-1.min-1) | 36.6 ± 9.3 (31.2–42.0) | 58.0 ± 7.5 (55.2–61.6) | 0.028 |
| Pulmonary ventilation (L.min-1) | 103.5 ± 17.6 (93.3–113.7) | 112.4 ± 14.9 (106.1–118.7) | 0.106 |
SBP: systolic blood pressure; DBP: diastolic blood pressure; PG: powerlifters group; RG: long-distance runners group. VO2: oxygen uptake; VCO2: carbon dioxide production. Differences between means were assessed by Student’s t Test for independent samples.
p < 0.05 vs. baseline value within the same group.
Echocardiographic parameters
| PG (n = 16) | RG (n = 24) | p-value | ||
|---|---|---|---|---|
| Aorta diameter (mm) | 31.3 ± 3 (29.7–32.9) | 32.0 ± 2.7 (30.8–33.2) | 0.410 | |
| LA diameter (mm) | 36.0 ± 2.5 (34.6–37.3) | 35.6 ± 2 (34.7–36.5) | 0.632 | |
| RV diameter (mm) | 20.3 ± 1.2 (19.6–20.9) | 20.5 ± 2 (19.6–21.4) | 0.689 | |
| LV end-systolic diameter (mm) | 30.7 ± 3.9 (28.6–32.8) | 30.2 ± 2.9 (28.9–31.5) | 0.671 | |
| LV end-diastolic diameter (mm) | 53.4 ± 3.3 (51.5–55.3) | 53.7 ± 3.3 (52.2–55.2) | 0.770 | |
| Interventricular septum thickness (mm) | 12.0 ± 1.0 (10.6–12.3) | 9.6 ± 0.4 (9.4–9.9) | < 0.001 | |
| Ventricular posterior wall thickness (mm) | 10.4 ± 0.9 (9.9–10.9) | 9.1 ± 0.5 (8.9–9.4) | < 0.001 | |
| LV mass (g) | 282.2 ± 73.4 (243–321.4) | 235.7 ± 26.0 (224.2–247.3) | < 0.001 | |
| LV mass/BSA (g/m2) | 135.6 ± 24.9 (136.1–133.6) | 127.8 ± 16.9 (120.3–135.4) | 0.262 | |
| End-diastolic volume (mL) | 145.0 ± 18.9 (134.9–155.1) | 138.1 ± 17.2 (130.5–145.8) | 0.251 | |
| Transmitral E-wave velocity | 0.83 ± 0.15 (0.75–0.90) | 0.91 ± 0.15 (0.84–0.97) | 0.124 | |
| e’ wave | 0.15 ± 0.03 (0.13–0.17) | 0.17 ± 0.34 (0.15–0.19) | 0.062 | |
| E/e’ ratio | 5.69 ± 1.05 (5.12–6.24) | 5.56 ± 1.76 (4.78–6.34) | 0.808 | |
| Transmitral A-wave velocity | 0.35 ± 0.03 (0.33–0.37) | 0.38 ± 0.04 (0.36–0.40) | 0.047 | |
| LA volume (mL) | 35.7 ± 8.5 (31.2–40.2) | 43.6 ± 10.2 (39.1–48.2) | 0.016 | |
| LA volume/BSA (mL/m2) | 16.7 ± 4.1 (14.5–18.8) | 23.4 ± 4.6 (21.4–25.5) | < 0.001 | |
| End-systolic volume (mL) | 38.0 ± 11.2 (31.9–44) | 34.8 ± 9.3 (30.6–38.9) | 0.348 | |
| Ejection fraction (%) | 73.0 ± 4.5 (70.5–75.4) | 74.3 ± 4.6 (72.3–76.3) | 0.383 | |
| Ejection fraction by Simpson’s rule (%) | 71.6 ± 4.8 (69.1–74.2) | 72.7 ± 5.9 (70.1–75.4) | 0.568 |
PG: powerlifters group; RG: long-distance runners group; LA: left atrium; RV: right ventricle; LV: left ventricle; BSA: body surface area. Differences between means were assessed using Student’s t Test for independent samples.
Figure 1Flow-mediated dilation measurements and peripheral vascular resistance. PG: powerlifters group, RG: long-distance runners group. The differences were assessed by Student’s t Test for independent samples.
Pearson linear correlation coefficients between training parameters and echocardiographic /cardiopulmonary variables (PG = 16)
| Total load (kg) | Duration of strength | Weekly duration of | Daily duration of | |
|---|---|---|---|---|
| Interventricular septum thickness (mm) | 0.733 | 0.411 | 0.286 | 0.212 |
| Posterior ventricular wall thickness (mm) | 0.680 | 0.365 | 0.274 | 0.225 |
| LV mass (g) | 0.689 | 0.407 | 0.213 | 0.248 |
| Resting heart rate (bpm) | 0.706 | 0.505 | –0.149 | 0.201 |
| Baseline SBP (mmHg) | 0.029 | 0.377 | 0.258 | 0.453 |
| Baseline DBP (mmHg) | 0.490 | 0.762 | 0.581 | 0.151 |
| VO2 max (mL.kg-1.min-1) | –0.459 | –0.093 | 0.048 | 0.135 |
| VCO2 max (mL.kg-1.min-1) | –0.623 | –0.133 | –0.051 | –0.022 |
PG: powerlifters group; 1-RM: one-repetition maximum test; LV: left ventricle, SBP: systolic blood pressure; DBP: diastolic blood pressure; VO2: oxygen uptake; VCO2: carbon dioxide production. Significance level
p < 0.001 and
p < 0.05.
Pearson linear correlation coefficients between training parameters and echocardiographic variables (RG = 24)
| VO2 max | VCO2
max | Pulmonary | Duration of strength | Weekly duration | Daily duration of | |
|---|---|---|---|---|---|---|
| Interventricular septum thickness (mm) | –0.640 | 0.362 | 0.303 | –0.630 | 0.150 | 0.136 |
| Posterior ventricular wall thickness (mm) | 0.001 | –0.016 | 0.209 | 0.260 | –0.139 | 0.032 |
| LV mass (g) | –0.140 | –0.137 | –0.015 | –0.110 | –0.248 | –0.100 |
| Resting heart rate (bpm) | –0.650 | –0.550 | –0.414 | –0.659 | –0.163 | –0.244 |
| Baseline SBP (mmHg) | 0.177 | 0.311 | 0.341 | –0.074 | –0.023 | –0.212 |
| Baseline DBP (mmHg) | 0.183 | 0.279 | 0.258 | 0.701 | 0.254 | –0.101 |
RG: long-distance runners group; LV: left ventricle; SBP: systolic blood pressure; DBP: diastolic blood pressure; VO2: oxygen uptake, VCO2: carbon dioxide production. Significance level
p < 0.05.
Pearson linear correlation coefficients between training parameters and brachial artery flow-mediated dilation measurements
| Squat (kg) | Bench | Deadlift (kg) | VO2 max
(mL. | Resting heart | Duration | Weekly | Daily duration | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PG | RG | PG | RG | PG | RG | PG | RG | PG | RG | PG | RG | PG | RG | PG | RG | |
| FMD (%) | 0.710 | 0.351 | 0.242 | 0.165 | 0.654 | –0.383 | 0.073 | –0.349 | 0.489 | –0.107 | 0.688 | 0.165 | 0.491 | –0.123 | 0.770 | –0.079 |
PG: powerlifters group; RG: long-distance runners group; FMD: flow-mediated dilation. Significance level
< 0.001,
p < 0.05.